# The association between high atherogenic index of plasma and impaired lung function: a population-based study

**Authors:** Liang Yang, Yuanzhou Wu, Ling Chen, Zizhao Li, Wenfei Zhu, Ziyan Zhang, Hui Li, Yang Huang, Qunqing Chen

PMC · DOI: 10.3389/fmed.2025.1589605 · 2025-07-09

## TL;DR

High atherogenic index of plasma (AIP) is linked to worse lung function, especially in women, suggesting it could help assess lung health.

## Contribution

This study reveals a novel sex-specific non-linear relationship between AIP and lung function in a large population.

## Key findings

- Elevated AIP is independently associated with reduced FEV1 and FVC lung function metrics.
- Females show a U-shaped non-linear decline in lung function at specific AIP thresholds.
- Males exhibit a consistent negative correlation between AIP and lung function across all levels.

## Abstract

Although AIP is a recognized cardiovascular risk marker, its association with pulmonary function and sex-specific differences remains unclear. This study investigated whether elevated AIP is independently associated with reduced lung function and examined potential sex-specific patterns.

Data from 4,565 participants in the NHANES 2007–2012 dataset were analyzed using a cross-sectional design. AIP served as the exposure variable, with five lung function metrics (including FEV1, FVC, and FEV1/FVC ratio) as outcomes. Weighted multiple linear regression, threshold effect analysis, subgroup comparisons, and XGBoost modeling were performed to assess associations.

Multivariable regression showed a significant negative association between AIP and FEV1 (β = −121.3 mL/unit, p < 0.001) and FVC (β = −147.1 mL/unit, p < 0.001), with no significant link to FEV1/FVC ratio. Subgroup analysis revealed a U-shaped non-linear association in females, with inflection points at AIP values of 0.77 (FEV1) and 0.78 (FVC), beyond which declines in lung function plateaued. Males exhibited a consistent negative correlation across all AIP levels.

Elevated AIP is independently associated with reduced lung function, particularly non-linear effects in females. These findings support AIP as a potential adjunct marker for pulmonary function assessment in clinical practice.

## Full-text entities

- **Genes:** AIP (AHR interacting HSP90 co-chaperone) [NCBI Gene 9049] {aka ARA9, FKBP16, FKBP37, PITA1, SMTPHN, XAP-2}
- **Diseases:** atherogenic (MESH:D050197), impaired lung function (MESH:D003072), reduced lung function (MESH:D001523)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12283284/full.md

---
Source: https://tomesphere.com/paper/PMC12283284